Health committee  Thank you, Dr. Morris, and thank you, Mr. Chair. These questions are very important to answer. I don't think we have the answer to those right now, and they should be studied. It is very important to know the effect of the second dose on maturing the immune response in a safe an

Health committee  I would have declared my interest, and I don't remember. Roger.

Health committee  Thank you for the question. To clarify, the research chair that I hold was an endowment that started to be developed between 2000...and was ultimately posted as an application on the Canadian Institutes of Health Research website. The endowment funds came from the Canadian Insti

Health committee  Thank you. I think it's important to understand if there is a conflict of interest. In this case, I have no material benefit to gain from an endowment that's held at Dalhousie University. I'll turn to Roger Scott-Douglas to explain the process for the management of conflicts of

Health committee  I can start, Mr. Chair. Thank you very much for the question and the wonderful summary of the evidence so far. I think your summary has highlighted a couple of points, and I'll just deal with them briefly. One is that each trial has a slightly different efficacy outcome. When

Health committee  I think your question is whether the relationship between the company and the U.S. is affecting Canada. I believe they're independent contracts. I'm not sure that they're procured from the same factories. Roger, can you fill in the details there?

Health committee  Mr. Chair, the vaccine task force is not responsible for the rollout. As an individual, I think it's a huge endeavour that we don't have regular practice with. I think we will learn from this in terms of pandemic planning and how to better deliver mass vaccination rollout progr

Health committee  Thank you, Mr. Chair, for the question about the minutes of the COVID-19 Vaccine Task Force. To date, the limits on the minutes of the task force are related to the confidential business information the task force considers. We've tried to overcome this by holding a number of me

Health committee  With regard to that particular vaccine, there are two separate processes. The first was a research agreement with Dalhousie University and CanSino, which was a result of the scientific collaboration between CanSino and the NRC. That happened before the task force. Second, CanS

Health committee  I think the assumption there is not quite correct. I don't believe—and Roger can explain this—that there was not actually intellectual property transferred.

Health committee  Thank you. Good afternoon. My name is Joanne Langley, and I am speaking to you today from Nova Scotia. I'd like to start by acknowledging that my workplace here at Dalhousie University and the IWK Health Centre sit on the ancestral and unceded territory of the Mi'kmaq. Thank

Health committee  Thank you. I use the word “fragile” because a robust immunization program requires public confidence, high vaccine uptake, funding and surveillance to measure the impact of vaccine programs, and ongoing research. I hope that this pandemic has sharpened our focus on the detectio